Quadriga BioSciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1
Completed
- Conditions
- AstrocytomaBrain MetastasesGastric CancerKidney CancerMelanomaSarcomaBladder CancerBreast CancerColorectal CancerPancreatic Cancer
- Interventions
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Quadriga Biosciences, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04430842
- Locations
- 🇦🇺
St George Private Hospital, Kogarah, New South Wales, Australia
🇦🇺Sydney Southwest Private Hospital, Liverpool, New South Wales, Australia
News
No news found